Clinical Trial Update: COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial) [Phase 3]

View source ↗

Summary

This update discusses the COPPS-2 Phase 3 trial evaluating colchicine to prevent post-pericardiotomy syndrome and post-operative atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Pericardial Effusion
• Pleural Effusion
• Post-pericardiotomy Syndrome

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Maria Vittoria Hospital | Conditions: Cardiac Surgery, Post-pericardiotomy Syndrome | Phase 3 | Status: UNKNOWN